Sign in

CIK 0001810182

  • Non-accelerated filer
  • Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850642577
Phone
+1 650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Chief Medical Officer sold 7,387 shares at an average $60.88 ($449,697)
  7. 4 Open-market sale President & CEO sold 16,700 shares at an average $55.71 ($930,276)
  8. 4/A Derivatives Options or other derivatives
  9. 4 Open-market sale Chief Medical Officer sold 7,387 shares at an average $61.97 ($457,772)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale President & CEO sold 16,700 shares at an average $57.63 ($962,433)
  13. 4 Open-market sale Chief Medical Officer sold 7,387 shares at an average $59.43 ($438,978)
  14. 4 Exercise or conversion President & CEO acquired 10,000 shares (option exercise)
  15. 4 Open-market sale President and CEO sold 16,700 shares at an average $68.49 ($1,143,860)
  16. 4 Open-market sale Chief Medical Officer sold 7,387 shares at an average $74.34 ($549,173)
  17. 4 Exercise or conversion Chief Financial Officer acquired 6,128 shares (option exercise)
  18. 4 Exercise or conversion President & CEO acquired 10,000 shares (option exercise)
  19. 4 Open-market buy Director bought 20,000 shares at $76.00 ($1,520,000)
  20. 4 Open-market buy 10% owner bought 400,000 shares at $19.00 ($7,600,000)

Page 9 of 11 · 213 filings